Filter Results :

Your search for inhibitors returned 467 reports

Sort by


Competitor Analysis: IDO & TDO Inhibitors - Novel Immune Response Checkpoint Modulators

01 Mar 2015  |  Published by:  La Merie Business Intelligence
The Competitive Intelligence report aboutIDO & TDO Inhibitors - Novel Immune Response Checkpoint Modulators provides a competitor analysis as of March 2015 in the development pipeline of novel inhibitors of indoleamine 2,3-dioxygenase (IDO) and tryptophan 2,3- dioxygenase (TDO) for treatme...

$ 163.31

Read More

Competitor Analysis: Alpha Synuclein and LRRK2 Inhibitors - Novel Drug Candidates for Parkinson's Disease

21 Jan 2015  |  Published by:  La Merie Business Intelligence
The Competitive Intelligence report about Alpha Synuclein and LRRK2 Inhibitors - Novel Drug Candidates for Parkinsonĺs Disease provides a competitor analysis in the discovery and development pipeline of novel therapeutics for treatment of Parkinsonĺs Disease (PD). Alpha-synuclein and leucine-r...

$ 217.75

Read More

Global Proton Pump Inhibitors Industry 2014 Market Research Report

10 Jan 2015  |  Published by:  9Dimen Research
2014 GlobalChlorhexidine Acetate Industry Report is a professional and in-depth research report on the world's major regional market conditions of theChlorhexidine Acetate industry, focusing on the main regions (North America, Europe and Asia) and the main countries (United States, Germany, Japan an...

$ 2,850.00

Read More

Plasma Fractionation Market by Product (Albumin, Immunoglobulin, Factor VIII, Protease Inhibitors), Application (Neurology, Immunology, Hematology, Critical Care) & by End-user (Hospitals, Clinical Research Laboratories) - Global Forecast to 2019

16 Dec 2014  |  Published by:  MarketsandMarkets
Report Description Over the last five years, the plasma fractionation market witnessed tremendous growth, primarily due to the growth in aging population, increasing number of hemophilic patients, rising use of IVIg, and high prevalence of chronic disorders across the globe. In this rep...

$ 4,650.00

Read More

Baking Ingredients Market by Type (Enzymes, Emulsifiers, Leavening agents, Fats & Shortenings, Mold Inhibitors, Colors & Flavors), Application (Bread, Biscuits & Cookies, Cakes & Pastries, Rolls & Pies) & Region - Global Trends & Forecast to 2019

24 Nov 2014  |  Published by:  MarketsandMarkets
Baking ingredients are widely used in baking applications such as bread, biscuits & cookies, cakes & pastries, rolls & pies, pizzas, donuts, and frozen baked products. These ingredients are used to enhance product quality, reduce production costs, save time, and increase the shelf-...

$ 4,650.00

Read More

Global Cancer Kinase Inhibitors Market & Pipeline Insight

01 Oct 2014  |  Published by:  KuicK Research
The recent years have witnessed the emergence of kinase inhibitors, which have the potential to offer less toxic and more efficient therapeutic alternatives for patients. Over the past two decades, the researchers have increased their learning about the functioning of these inhibitors, which h...

$ 2,400.00

Read More

5-Lipoxygenase Activating Protein (FLAP) Inhibitors -Pipeline Insights, 2014

01 Aug 2014  |  Published by:  DelveInsight
Summary'5-Lipoxygenase Activating Protein (FLAP) Inhibitors-Pipeline Insights, 2014', report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report is to establish the understanding for all the pipeline drugs that fall under 5-Lipoxy...

$ 1,250.00

Read More

5-Alpha Reductase Inhibitors -Pipeline Insights, 2014

01 Aug 2014  |  Published by:  DelveInsight
Summary'5-Alpha Reductase Inhibitors-Pipeline Insights, 2014', report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report is to establish the understanding for all the pipeline drugs that fall under 5-Alpha Reductase Inhibitors. T...

$ 1,250.00

Read More

11 Beta-Hydroxysteroid Dehydrogenase (11▀HSD) Inhibitors -Pipeline Insights, 2014

01 Aug 2014  |  Published by:  DelveInsight
Summary'11 Beta-Hydroxysteroid Dehydrogenase (11▀HSD) Inhibitors-Pipeline Insights, 2014', report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report is to establish the understanding for all the pipeline drugs that fall under 11 ...

$ 1,250.00

Read More

1,3-Beta-Glucan Synthase Inhibitors -Pipeline Insights, 2014

01 Aug 2014  |  Published by:  DelveInsight
Summary'1,3-Beta-Glucan Synthase Inhibitors-Pipeline Insights, 2014', report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report is to establish the understanding for all the pipeline drugs that fall under 1,3-Beta-Glucan Synthase...

$ 1,250.00

Read More

5-Lipoxygenase Inhibitors (Arachidonate 5-Lipoxygenase Inhibitors) -Pipeline Insights, 2014

01 Aug 2014  |  Published by:  DelveInsight
Summary'5-Lipoxygenase Inhibitors (Arachidonate 5-Lipoxygenase Inhibitors)-Pipeline Insights, 2014', report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report is to establish the understanding for all the pipeline drugs that fall...

$ 1,250.00

Read More

50S Ribosomal Subunit (50S RNA) Inhibitors -Pipeline Insights, 2014

01 Aug 2014  |  Published by:  DelveInsight
Summary'50S Ribosomal Subunit (50S RNA) Inhibitors-Pipeline Insights, 2014', report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report is to establish the understanding for all the pipeline drugs that fall under 50S Ribosomal Sub...

$ 1,250.00

Read More

30S Ribosomal Subunit (30S RNA) Inhibitors -Pipeline Insights, 2014

01 Aug 2014  |  Published by:  DelveInsight
Summary'30S Ribosomal Subunit (30S RNA) Inhibitors-Pipeline Insights, 2014', report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report is to establish the understanding for all the pipeline drugs that fall under 30S Ribosomal Sub...

$ 1,250.00

Read More

20s Proteasome Inhibitors -Pipeline Insights, 2014

01 Aug 2014  |  Published by:  DelveInsight
Summary'20s Proteasome Inhibitors-Pipeline Insights, 2014', report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report is to establish the understanding for all the pipeline drugs that fall under 20s Proteasome Inhibitors. This re...

$ 1,250.00

Read More

11 Beta-Hydroxysteroid Dehydrogenase Type 1 (11▀HSD1) Inhibitors -Pipeline Insights, 2014

01 Aug 2014  |  Published by:  DelveInsight
Summary'11 Beta-Hydroxysteroid Dehydrogenase Type 1 (11▀HSD1) Inhibitors-Pipeline Insights, 2014', report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report is to establish the understanding for all the pipeline drugs that fall u...

$ 1,250.00

Read More
Total 467 records.